Oral Cavity Cancer Clinical Trials

A listing of Oral Cavity Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 84 clinical trials
A New Membrane Obturator Prothesis Concept for Soft Palate Defects

When soft palate defects lead to palatal insufficiency, the patient's quality of life is affected by difficulties swallowing, hypernasality, and poor intelligibility of speech. If immediate surgical reconstruction is not an option, the patient may benefit from the placement of a rigid obturator prosthesis. Unfortunately, the residual muscle stumps are …

stiff
obturator prosthesis
  • 0 views
  • 24 Jan, 2021
  • 2 locations
Carboplatin Nab-Paclitaxel Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Participants in this study have a type of cancer called squamous cell carcinoma of the head and neck (SCCHN). Their SCCHN has spread around the area where the cancer first started. This is called locally-advanced SCCHN. These participants are eligible for surgery. Previous research with a similar therapy regimen resulted …

chemotherapy regimen
cancer
measurable disease
head and neck carcinoma
squamous cell carcinoma of the head and neck
  • 101 views
  • 24 Jan, 2021
  • 2 locations
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

This is a prospective, multi-center, open-label, non-randomized, multi-arm phase II trial to evaluate the efficacy of combination therapy with pembrolizumab and cetuximab for patients with recurrent/metastatic HNSCC. There will be four patient cohorts, including a PD-1/PD-L1 inhibitor-nave, cetuximab-nave arm (Cohort 1), a PD-1/PD-L1 inhibitor-refractory, cetuximab-nave arm (Cohort 2), a PD-1/PD-L1 …

cancer
carcinoma
head and neck carcinoma
squamous cell carcinoma of the head and neck
caries
  • 508 views
  • 21 Mar, 2021
  • 4 locations
EHR-embedded OCDT in Breast or GI Cancer

This is research study is for participants with advanced breast or gastrointestinal cancer who have been taking oral chemotherapy medication (Oral Cancer Directed Therapy). This study is to help

cancer
advanced breast cancer
  • 3 views
  • 26 Apr, 2021
STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03

treatment of early stage oropharyngeal and oral cavity cancer with high risk margins.

mouth cancer
cancer
oropharyngeal
carcinoma
oral cavity cancer
  • 4 views
  • 25 Jan, 2021
  • 23 locations
Alpha Radiation Emitters Device for the Treatment of Cutaneous Mucosal and Superficial Soft Tissue Neoplasia (DaRT)

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

cancer
cancer treatment
  • 0 views
  • 27 Jul, 2021
  • 1 location
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation therapy (RT) in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).

mouth cancer
head and neck cancer
cancer
carcinoma
measurable disease
  • 0 views
  • 18 Feb, 2021
  • 7 locations
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

This study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.

head and neck cancer
cancer
metastatic head and neck cancer
advanced head and neck cancer
carcinoma
  • 0 views
  • 02 Jul, 2021
  • 1 location
Alpha Radiation Emitters Device for the Treatment of Cutaneous Mucosal or Superficial Soft Tissue Neoplasia (DaRT)

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

cancer
cancer treatment
platelet count
cavity
  • 0 views
  • 25 Mar, 2021
  • 1 location
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous Mucosal or Superficial Soft Tissue Neoplasia.

A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia

cancer treatment
cavity
cancer
platelet count
measurable disease
  • 0 views
  • 30 Jan, 2021
  • 1 location